avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Runx2
|
ENSMUSG00000039153.18 | Runx2 |
Bcl11a
|
ENSMUSG00000000861.16 | Bcl11a |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Runx2 | mm39_v1_chr17_-_45125468_45125525 | 0.64 | 2.4e-05 | Click! |
Bcl11a | mm39_v1_chr11_+_24028022_24028076 | 0.64 | 2.4e-05 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr18_-_35782412 | 27.38 |
ENSMUST00000025211.6
|
Mzb1
|
marginal zone B and B1 cell-specific protein 1 |
chr11_-_87766350 | 23.50 |
ENSMUST00000049768.4
|
Epx
|
eosinophil peroxidase |
chr7_-_140596811 | 22.16 |
ENSMUST00000081924.5
|
Ifitm6
|
interferon induced transmembrane protein 6 |
chr11_+_87684548 | 21.25 |
ENSMUST00000143021.9
|
Mpo
|
myeloperoxidase |
chr11_+_87684299 | 20.70 |
ENSMUST00000020779.11
|
Mpo
|
myeloperoxidase |
chr19_-_20368029 | 19.60 |
ENSMUST00000235280.2
|
Anxa1
|
annexin A1 |
chr7_-_103477126 | 18.99 |
ENSMUST00000023934.8
|
Hbb-bs
|
hemoglobin, beta adult s chain |
chr17_+_33857030 | 18.86 |
ENSMUST00000052079.8
|
Pram1
|
PML-RAR alpha-regulated adaptor molecule 1 |
chr5_+_90916370 | 17.82 |
ENSMUST00000031319.8
|
Ppbp
|
pro-platelet basic protein |
chr7_+_142559414 | 17.68 |
ENSMUST00000082008.12
ENSMUST00000105925.8 ENSMUST00000105924.8 |
Tspan32
|
tetraspanin 32 |
chr16_-_16681839 | 17.55 |
ENSMUST00000100136.4
|
Igll1
|
immunoglobulin lambda-like polypeptide 1 |
chr14_-_56499690 | 17.49 |
ENSMUST00000015581.6
|
Gzmb
|
granzyme B |
chr17_-_28779678 | 16.95 |
ENSMUST00000114785.3
ENSMUST00000025062.5 |
Clps
|
colipase, pancreatic |
chr11_-_106205320 | 16.63 |
ENSMUST00000167143.2
|
Cd79b
|
CD79B antigen |
chr7_+_142559375 | 16.08 |
ENSMUST00000075172.12
ENSMUST00000105923.8 |
Tspan32
|
tetraspanin 32 |
chr8_-_112417633 | 15.88 |
ENSMUST00000034435.7
|
Ctrb1
|
chymotrypsinogen B1 |
chr10_-_62215631 | 15.40 |
ENSMUST00000143236.8
ENSMUST00000133429.8 ENSMUST00000132926.8 ENSMUST00000116238.9 |
Hk1
|
hexokinase 1 |
chrX_-_7956682 | 15.39 |
ENSMUST00000033505.7
|
Was
|
Wiskott-Aldrich syndrome |
chr12_-_4924341 | 15.12 |
ENSMUST00000137337.8
ENSMUST00000045921.14 |
Mfsd2b
|
major facilitator superfamily domain containing 2B |
chr2_-_32277773 | 14.68 |
ENSMUST00000050785.14
|
Lcn2
|
lipocalin 2 |
chr7_+_24069680 | 14.52 |
ENSMUST00000205428.2
ENSMUST00000171904.3 ENSMUST00000205626.2 |
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr6_+_87755046 | 14.12 |
ENSMUST00000032133.5
|
Gp9
|
glycoprotein 9 (platelet) |
chr7_+_142558783 | 14.03 |
ENSMUST00000009396.13
|
Tspan32
|
tetraspanin 32 |
chr7_-_142220553 | 13.82 |
ENSMUST00000105935.8
|
Igf2
|
insulin-like growth factor 2 |
chr11_-_11920540 | 12.84 |
ENSMUST00000109653.8
|
Grb10
|
growth factor receptor bound protein 10 |
chr7_+_44221791 | 12.71 |
ENSMUST00000002274.10
|
Napsa
|
napsin A aspartic peptidase |
chr13_-_113237505 | 12.40 |
ENSMUST00000224282.2
ENSMUST00000023897.7 |
Gzma
|
granzyme A |
chr7_+_142558837 | 12.14 |
ENSMUST00000207211.2
|
Tspan32
|
tetraspanin 32 |
chr4_+_135899678 | 11.97 |
ENSMUST00000061721.6
|
E2f2
|
E2F transcription factor 2 |
chr17_+_47906985 | 11.91 |
ENSMUST00000182539.8
|
Ccnd3
|
cyclin D3 |
chr16_+_35977170 | 11.86 |
ENSMUST00000079184.6
|
Stfa2l1
|
stefin A2 like 1 |
chr19_-_5323092 | 11.29 |
ENSMUST00000237463.2
ENSMUST00000025786.9 |
Pacs1
|
phosphofurin acidic cluster sorting protein 1 |
chr9_+_110867807 | 11.20 |
ENSMUST00000197575.2
|
Ltf
|
lactotransferrin |
chr10_+_79722081 | 10.75 |
ENSMUST00000046091.7
|
Elane
|
elastase, neutrophil expressed |
chr17_-_35285146 | 10.73 |
ENSMUST00000174190.2
ENSMUST00000097337.8 |
Mpig6b
|
megakaryocyte and platelet inhibitory receptor G6b |
chr3_+_103767581 | 10.71 |
ENSMUST00000029433.9
|
Ptpn22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
chr16_-_36228798 | 10.55 |
ENSMUST00000023619.8
|
Stfa2
|
stefin A2 |
chr4_-_137157824 | 9.97 |
ENSMUST00000102522.5
|
Cela3b
|
chymotrypsin-like elastase family, member 3B |
chr17_+_36132567 | 9.94 |
ENSMUST00000003635.7
|
Ier3
|
immediate early response 3 |
chr2_-_172212426 | 9.59 |
ENSMUST00000109139.8
ENSMUST00000028997.8 ENSMUST00000109140.10 |
Aurka
|
aurora kinase A |
chr17_+_37180437 | 9.22 |
ENSMUST00000060524.11
|
Trim10
|
tripartite motif-containing 10 |
chr5_+_90920294 | 9.19 |
ENSMUST00000031320.8
|
Pf4
|
platelet factor 4 |
chr14_+_66534478 | 9.14 |
ENSMUST00000022623.13
|
Trim35
|
tripartite motif-containing 35 |
chr10_-_79624758 | 8.73 |
ENSMUST00000020573.13
|
Prss57
|
protease, serine 57 |
chr11_-_69508706 | 8.72 |
ENSMUST00000005334.3
|
Shbg
|
sex hormone binding globulin |
chr7_-_24705320 | 8.59 |
ENSMUST00000102858.10
ENSMUST00000196684.2 ENSMUST00000080882.11 |
Atp1a3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
chr7_-_100512579 | 8.34 |
ENSMUST00000142885.2
ENSMUST00000008462.11 |
Relt
|
RELT tumor necrosis factor receptor |
chr10_+_75399920 | 8.34 |
ENSMUST00000141062.8
ENSMUST00000152657.8 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr2_-_27974889 | 8.17 |
ENSMUST00000028179.15
ENSMUST00000117486.8 ENSMUST00000135472.2 |
Fcnb
|
ficolin B |
chr6_-_87510200 | 8.11 |
ENSMUST00000113637.9
ENSMUST00000071024.7 |
Arhgap25
|
Rho GTPase activating protein 25 |
chr10_+_43455157 | 8.07 |
ENSMUST00000058714.10
|
Cd24a
|
CD24a antigen |
chr5_+_90920353 | 7.90 |
ENSMUST00000202625.2
|
Pf4
|
platelet factor 4 |
chr6_+_123100382 | 7.80 |
ENSMUST00000032248.8
|
Clec4a2
|
C-type lectin domain family 4, member a2 |
chr4_-_46404224 | 7.50 |
ENSMUST00000107764.9
|
Hemgn
|
hemogen |
chr11_-_102815910 | 7.37 |
ENSMUST00000021311.10
|
Kif18b
|
kinesin family member 18B |
chr15_-_78377926 | 7.36 |
ENSMUST00000163494.3
|
Il2rb
|
interleukin 2 receptor, beta chain |
chr6_+_123100272 | 7.33 |
ENSMUST00000041779.13
|
Clec4a2
|
C-type lectin domain family 4, member a2 |
chr7_+_142559475 | 7.29 |
ENSMUST00000143512.3
|
Tspan32
|
tetraspanin 32 |
chr7_+_43086432 | 7.24 |
ENSMUST00000070518.4
|
Nkg7
|
natural killer cell group 7 sequence |
chr11_-_79414542 | 7.20 |
ENSMUST00000179322.2
|
Evi2b
|
ecotropic viral integration site 2b |
chr7_-_140597465 | 7.18 |
ENSMUST00000211330.2
|
Ifitm6
|
interferon induced transmembrane protein 6 |
chr9_+_108356935 | 7.16 |
ENSMUST00000194147.2
ENSMUST00000065014.10 ENSMUST00000195483.6 ENSMUST00000195058.2 |
Lamb2
|
laminin, beta 2 |
chr7_+_45084257 | 7.00 |
ENSMUST00000003964.17
|
Gys1
|
glycogen synthase 1, muscle |
chrX_+_92698469 | 6.95 |
ENSMUST00000113933.9
|
Pcyt1b
|
phosphate cytidylyltransferase 1, choline, beta isoform |
chr6_+_123099615 | 6.89 |
ENSMUST00000161636.8
ENSMUST00000161365.8 |
Clec4a2
|
C-type lectin domain family 4, member a2 |
chr17_+_12338161 | 6.84 |
ENSMUST00000024594.9
|
Agpat4
|
1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta) |
chr1_+_135060994 | 6.74 |
ENSMUST00000167080.3
|
Ptpn7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr14_+_66534539 | 6.73 |
ENSMUST00000121006.2
|
Trim35
|
tripartite motif-containing 35 |
chr15_-_103163860 | 6.73 |
ENSMUST00000075192.13
|
Nfe2
|
nuclear factor, erythroid derived 2 |
chr5_+_149201577 | 6.54 |
ENSMUST00000071130.5
|
Alox5ap
|
arachidonate 5-lipoxygenase activating protein |
chr4_+_114914880 | 6.47 |
ENSMUST00000161601.8
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr1_+_172328768 | 6.42 |
ENSMUST00000111228.2
|
Tagln2
|
transgelin 2 |
chr3_-_86049988 | 6.37 |
ENSMUST00000029722.7
|
Rps3a1
|
ribosomal protein S3A1 |
chr1_+_135060431 | 6.37 |
ENSMUST00000187985.7
ENSMUST00000049449.11 |
Ptpn7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr8_+_110432132 | 6.35 |
ENSMUST00000212964.2
ENSMUST00000034163.9 |
Zfp821
|
zinc finger protein 821 |
chr15_-_66673425 | 6.17 |
ENSMUST00000168589.8
|
Sla
|
src-like adaptor |
chrX_-_56384089 | 6.16 |
ENSMUST00000033468.11
|
Arhgef6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
chrX_-_100311824 | 6.10 |
ENSMUST00000033664.14
|
Il2rg
|
interleukin 2 receptor, gamma chain |
chr2_-_32278245 | 6.06 |
ENSMUST00000192241.2
|
Lcn2
|
lipocalin 2 |
chr7_-_44888220 | 6.05 |
ENSMUST00000210372.2
ENSMUST00000209779.2 ENSMUST00000098461.10 ENSMUST00000211373.2 |
Cd37
|
CD37 antigen |
chr4_+_114914607 | 5.92 |
ENSMUST00000136946.8
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr13_+_36142822 | 5.88 |
ENSMUST00000225537.2
|
Ppp1r3g
|
protein phosphatase 1, regulatory subunit 3G |
chr19_-_34231600 | 5.83 |
ENSMUST00000238147.2
|
Acta2
|
actin, alpha 2, smooth muscle, aorta |
chr2_-_58050494 | 5.82 |
ENSMUST00000028175.7
|
Cytip
|
cytohesin 1 interacting protein |
chr7_+_43086554 | 5.75 |
ENSMUST00000206741.2
|
Nkg7
|
natural killer cell group 7 sequence |
chr8_+_89020845 | 5.65 |
ENSMUST00000098521.4
|
Adcy7
|
adenylate cyclase 7 |
chr12_-_78953703 | 5.52 |
ENSMUST00000021544.8
|
Plek2
|
pleckstrin 2 |
chr10_-_62343516 | 5.50 |
ENSMUST00000020271.13
|
Srgn
|
serglycin |
chr17_+_47908025 | 5.50 |
ENSMUST00000183206.2
|
Ccnd3
|
cyclin D3 |
chr7_+_45084300 | 5.45 |
ENSMUST00000211150.2
|
Gys1
|
glycogen synthase 1, muscle |
chr11_+_70529944 | 5.44 |
ENSMUST00000055184.7
ENSMUST00000108551.3 |
Gp1ba
|
glycoprotein 1b, alpha polypeptide |
chr3_+_51568588 | 5.40 |
ENSMUST00000099106.10
|
Mgst2
|
microsomal glutathione S-transferase 2 |
chr8_+_23525101 | 5.37 |
ENSMUST00000117662.8
ENSMUST00000117296.8 ENSMUST00000141784.9 |
Ank1
|
ankyrin 1, erythroid |
chr5_-_113957318 | 5.37 |
ENSMUST00000201194.4
|
Selplg
|
selectin, platelet (p-selectin) ligand |
chr18_-_73948501 | 5.29 |
ENSMUST00000025439.5
|
Me2
|
malic enzyme 2, NAD(+)-dependent, mitochondrial |
chr15_+_79578141 | 5.22 |
ENSMUST00000230898.2
ENSMUST00000229046.2 |
Gtpbp1
|
GTP binding protein 1 |
chr10_-_80382611 | 5.07 |
ENSMUST00000183233.9
ENSMUST00000182604.8 |
Rexo1
|
REX1, RNA exonuclease 1 |
chr13_-_37234213 | 4.98 |
ENSMUST00000164727.8
|
F13a1
|
coagulation factor XIII, A1 subunit |
chr7_-_13988795 | 4.98 |
ENSMUST00000184731.8
ENSMUST00000076576.7 |
Sult2a6
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 6 |
chr15_-_97742134 | 4.92 |
ENSMUST00000119670.8
ENSMUST00000116409.9 |
Hdac7
|
histone deacetylase 7 |
chr5_+_105667254 | 4.92 |
ENSMUST00000067924.13
ENSMUST00000150981.2 |
Lrrc8c
|
leucine rich repeat containing 8 family, member C |
chr8_+_22266580 | 4.92 |
ENSMUST00000051017.9
|
Defb1
|
defensin beta 1 |
chr7_-_126399208 | 4.90 |
ENSMUST00000133514.8
ENSMUST00000151137.8 |
Aldoa
|
aldolase A, fructose-bisphosphate |
chr15_+_80456775 | 4.87 |
ENSMUST00000229980.2
|
Grap2
|
GRB2-related adaptor protein 2 |
chr18_-_62313019 | 4.84 |
ENSMUST00000053640.5
|
Adrb2
|
adrenergic receptor, beta 2 |
chr11_-_106278892 | 4.79 |
ENSMUST00000106813.9
ENSMUST00000141146.2 |
Icam2
|
intercellular adhesion molecule 2 |
chr6_-_60806810 | 4.78 |
ENSMUST00000163779.8
|
Snca
|
synuclein, alpha |
chr14_-_70414236 | 4.78 |
ENSMUST00000153735.8
|
Pdlim2
|
PDZ and LIM domain 2 |
chr10_+_75407356 | 4.78 |
ENSMUST00000143226.8
ENSMUST00000124259.8 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr7_-_45083688 | 4.77 |
ENSMUST00000210439.2
|
Ruvbl2
|
RuvB-like protein 2 |
chr7_+_100142544 | 4.73 |
ENSMUST00000126534.8
ENSMUST00000207748.2 |
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr2_+_158148413 | 4.71 |
ENSMUST00000109491.8
ENSMUST00000016168.9 |
Lbp
|
lipopolysaccharide binding protein |
chr7_+_45224524 | 4.71 |
ENSMUST00000210811.2
|
Bcat2
|
branched chain aminotransferase 2, mitochondrial |
chr4_-_43499608 | 4.66 |
ENSMUST00000136005.3
ENSMUST00000054538.13 |
Arhgef39
|
Rho guanine nucleotide exchange factor (GEF) 39 |
chr13_-_55169100 | 4.65 |
ENSMUST00000148221.8
ENSMUST00000052949.13 |
Hk3
|
hexokinase 3 |
chr3_+_96737385 | 4.65 |
ENSMUST00000058865.14
|
Pdzk1
|
PDZ domain containing 1 |
chr2_-_73316053 | 4.61 |
ENSMUST00000102680.8
|
Wipf1
|
WAS/WASL interacting protein family, member 1 |
chr9_-_107960528 | 4.56 |
ENSMUST00000159372.3
ENSMUST00000160249.8 |
Rnf123
|
ring finger protein 123 |
chr5_-_113957362 | 4.55 |
ENSMUST00000202555.2
|
Selplg
|
selectin, platelet (p-selectin) ligand |
chr7_-_142209755 | 4.48 |
ENSMUST00000178921.2
|
Igf2
|
insulin-like growth factor 2 |
chr16_+_22710027 | 4.42 |
ENSMUST00000231848.2
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr13_+_28441511 | 4.40 |
ENSMUST00000223428.2
|
Rps18-ps5
|
ribosomal protein S18, pseudogene 5 |
chr5_-_113968483 | 4.37 |
ENSMUST00000100874.6
|
Selplg
|
selectin, platelet (p-selectin) ligand |
chr11_-_16958647 | 4.34 |
ENSMUST00000102881.10
|
Plek
|
pleckstrin |
chr13_-_55169000 | 4.34 |
ENSMUST00000153665.8
|
Hk3
|
hexokinase 3 |
chr17_+_29042640 | 4.32 |
ENSMUST00000233088.2
ENSMUST00000233182.2 ENSMUST00000233520.2 |
Brpf3
|
bromodomain and PHD finger containing, 3 |
chr16_+_22710134 | 4.27 |
ENSMUST00000231328.2
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr1_+_107456731 | 4.25 |
ENSMUST00000182198.8
|
Serpinb10
|
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 10 |
chr5_+_143534455 | 4.23 |
ENSMUST00000169329.8
ENSMUST00000067145.12 ENSMUST00000119488.2 ENSMUST00000118121.2 ENSMUST00000200267.2 ENSMUST00000196487.2 |
Fam220a
Fam220a
|
family with sequence similarity 220, member A family with sequence similarity 220, member A |
chr9_+_51124983 | 4.21 |
ENSMUST00000034554.9
|
Pou2af1
|
POU domain, class 2, associating factor 1 |
chr4_+_134847949 | 4.18 |
ENSMUST00000056977.14
|
Runx3
|
runt related transcription factor 3 |
chr8_-_120331936 | 4.13 |
ENSMUST00000093099.13
|
Taf1c
|
TATA-box binding protein associated factor, RNA polymerase I, C |
chr3_+_51568625 | 4.13 |
ENSMUST00000159554.7
ENSMUST00000161590.4 |
Mgst2
|
microsomal glutathione S-transferase 2 |
chr4_-_41275091 | 4.12 |
ENSMUST00000030143.13
ENSMUST00000108068.8 |
Ubap2
|
ubiquitin-associated protein 2 |
chr10_+_3923086 | 4.11 |
ENSMUST00000117291.8
ENSMUST00000120585.8 ENSMUST00000043735.8 |
Mthfd1l
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
chr14_-_51384236 | 4.10 |
ENSMUST00000080126.4
|
Rnase1
|
ribonuclease, RNase A family, 1 (pancreatic) |
chr6_+_86605146 | 4.06 |
ENSMUST00000043400.9
|
Asprv1
|
aspartic peptidase, retroviral-like 1 |
chr11_-_72441054 | 4.03 |
ENSMUST00000021154.7
|
Spns3
|
spinster homolog 3 |
chr4_-_118314647 | 4.00 |
ENSMUST00000106375.2
ENSMUST00000168404.9 ENSMUST00000006556.11 |
Mpl
|
myeloproliferative leukemia virus oncogene |
chr7_-_43182595 | 3.97 |
ENSMUST00000205503.2
|
Cd33
|
CD33 antigen |
chr7_+_102090892 | 3.95 |
ENSMUST00000033283.10
|
Rrm1
|
ribonucleotide reductase M1 |
chr8_-_85567256 | 3.92 |
ENSMUST00000003911.13
ENSMUST00000109761.9 ENSMUST00000128035.2 |
Rad23a
|
RAD23 homolog A, nucleotide excision repair protein |
chr16_-_18884431 | 3.92 |
ENSMUST00000200235.2
|
Iglc3
|
immunoglobulin lambda constant 3 |
chr9_+_72345267 | 3.90 |
ENSMUST00000183809.8
|
Mns1
|
meiosis-specific nuclear structural protein 1 |
chr1_+_172327812 | 3.89 |
ENSMUST00000192460.2
|
Tagln2
|
transgelin 2 |
chr7_-_43182504 | 3.89 |
ENSMUST00000004728.12
|
Cd33
|
CD33 antigen |
chr17_-_35304582 | 3.89 |
ENSMUST00000038507.7
|
Ly6g6f
|
lymphocyte antigen 6 complex, locus G6F |
chr16_-_18107046 | 3.88 |
ENSMUST00000232424.2
ENSMUST00000009321.11 |
Dgcr8
|
DGCR8, microprocessor complex subunit |
chr11_+_82955917 | 3.86 |
ENSMUST00000038038.8
|
Slfn2
|
schlafen 2 |
chr16_-_16687119 | 3.84 |
ENSMUST00000075017.5
|
Vpreb1
|
pre-B lymphocyte gene 1 |
chr14_-_56322654 | 3.83 |
ENSMUST00000015594.9
|
Mcpt8
|
mast cell protease 8 |
chr16_-_18880821 | 3.80 |
ENSMUST00000200568.2
|
Iglc1
|
immunoglobulin lambda constant 1 |
chr8_+_110432210 | 3.79 |
ENSMUST00000212192.2
|
Zfp821
|
zinc finger protein 821 |
chr5_-_124325213 | 3.77 |
ENSMUST00000161938.8
|
Pitpnm2
|
phosphatidylinositol transfer protein, membrane-associated 2 |
chr5_-_113970664 | 3.76 |
ENSMUST00000199109.2
|
Selplg
|
selectin, platelet (p-selectin) ligand |
chr13_+_54519161 | 3.70 |
ENSMUST00000026985.9
|
Cplx2
|
complexin 2 |
chr14_-_56299764 | 3.69 |
ENSMUST00000043249.10
|
Mcpt4
|
mast cell protease 4 |
chr10_-_23663086 | 3.67 |
ENSMUST00000073926.8
|
Rps12
|
ribosomal protein S12 |
chr17_-_26161797 | 3.67 |
ENSMUST00000208043.2
ENSMUST00000148382.2 ENSMUST00000145745.3 |
Pigq
|
phosphatidylinositol glycan anchor biosynthesis, class Q |
chr8_-_123187406 | 3.65 |
ENSMUST00000006762.7
|
Snai3
|
snail family zinc finger 3 |
chr1_+_172327569 | 3.64 |
ENSMUST00000111230.8
|
Tagln2
|
transgelin 2 |
chr7_-_44888532 | 3.62 |
ENSMUST00000033063.15
|
Cd37
|
CD37 antigen |
chr9_+_107852733 | 3.61 |
ENSMUST00000035216.11
|
Uba7
|
ubiquitin-like modifier activating enzyme 7 |
chr2_+_26800757 | 3.61 |
ENSMUST00000102898.5
|
Rpl7a
|
ribosomal protein L7A |
chr3_+_145855929 | 3.60 |
ENSMUST00000098524.5
|
Mcoln2
|
mucolipin 2 |
chr6_+_66512401 | 3.59 |
ENSMUST00000101343.2
|
Mad2l1
|
MAD2 mitotic arrest deficient-like 1 |
chr11_+_101137786 | 3.55 |
ENSMUST00000107282.4
|
Ramp2
|
receptor (calcitonin) activity modifying protein 2 |
chr2_+_31649946 | 3.55 |
ENSMUST00000028190.13
|
Abl1
|
c-abl oncogene 1, non-receptor tyrosine kinase |
chr1_-_171061902 | 3.49 |
ENSMUST00000079957.12
|
Fcer1g
|
Fc receptor, IgE, high affinity I, gamma polypeptide |
chr18_+_61238714 | 3.49 |
ENSMUST00000237706.2
|
Csf1r
|
colony stimulating factor 1 receptor |
chr4_+_134238310 | 3.46 |
ENSMUST00000105866.3
|
Aunip
|
aurora kinase A and ninein interacting protein |
chr14_+_56091454 | 3.46 |
ENSMUST00000227465.2
ENSMUST00000168479.3 ENSMUST00000100529.10 |
Nynrin
|
NYN domain and retroviral integrase containing |
chr11_-_69786324 | 3.46 |
ENSMUST00000001631.7
|
Acap1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr4_-_118314707 | 3.44 |
ENSMUST00000102671.10
|
Mpl
|
myeloproliferative leukemia virus oncogene |
chr11_+_75422516 | 3.41 |
ENSMUST00000149727.8
ENSMUST00000108433.8 ENSMUST00000042561.14 ENSMUST00000143035.8 |
Slc43a2
|
solute carrier family 43, member 2 |
chr16_-_38253507 | 3.39 |
ENSMUST00000002926.8
|
Pla1a
|
phospholipase A1 member A |
chr11_-_83540175 | 3.38 |
ENSMUST00000001008.6
|
Ccl3
|
chemokine (C-C motif) ligand 3 |
chr10_-_23663109 | 3.37 |
ENSMUST00000218221.2
ENSMUST00000218107.2 |
Rps12
|
ribosomal protein S12 |
chr15_+_79775894 | 3.37 |
ENSMUST00000177483.8
|
Apobec3
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3 |
chr19_+_3985186 | 3.37 |
ENSMUST00000165711.3
ENSMUST00000162708.7 ENSMUST00000236920.2 |
Unc93b1
|
unc-93 homolog B1, TLR signaling regulator |
chr7_-_44888465 | 3.35 |
ENSMUST00000210078.2
|
Cd37
|
CD37 antigen |
chrX_-_100312629 | 3.33 |
ENSMUST00000117736.2
|
Gm20489
|
predicted gene 20489 |
chr10_+_126899468 | 3.31 |
ENSMUST00000120226.8
ENSMUST00000133115.8 |
Cdk4
|
cyclin-dependent kinase 4 |
chr15_-_97742045 | 3.29 |
ENSMUST00000120683.8
|
Hdac7
|
histone deacetylase 7 |
chr4_+_132903646 | 3.27 |
ENSMUST00000105912.2
|
Wasf2
|
WASP family, member 2 |
chr11_-_102907991 | 3.24 |
ENSMUST00000021313.9
|
Dcakd
|
dephospho-CoA kinase domain containing |
chr7_-_19410749 | 3.23 |
ENSMUST00000003074.16
|
Apoc2
|
apolipoprotein C-II |
chr2_-_152239966 | 3.21 |
ENSMUST00000063332.9
ENSMUST00000182625.2 |
Sox12
|
SRY (sex determining region Y)-box 12 |
chr4_+_41569775 | 3.20 |
ENSMUST00000102963.10
|
Dnai1
|
dynein axonemal intermediate chain 1 |
chrX_+_149330371 | 3.16 |
ENSMUST00000066337.13
ENSMUST00000112715.2 |
Alas2
|
aminolevulinic acid synthase 2, erythroid |
chr2_+_24235300 | 3.16 |
ENSMUST00000114485.9
ENSMUST00000114482.3 |
Il1rn
|
interleukin 1 receptor antagonist |
chr11_-_115405200 | 3.14 |
ENSMUST00000021083.7
|
Jpt1
|
Jupiter microtubule associated homolog 1 |
chr3_-_135313982 | 3.12 |
ENSMUST00000132668.8
|
Nfkb1
|
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
chr14_-_54754810 | 3.10 |
ENSMUST00000023873.12
|
Prmt5
|
protein arginine N-methyltransferase 5 |
chrX_-_9335525 | 3.08 |
ENSMUST00000015484.10
|
Cybb
|
cytochrome b-245, beta polypeptide |
chr7_-_3723381 | 3.06 |
ENSMUST00000078451.7
|
Pirb
|
paired Ig-like receptor B |
chr4_-_116851550 | 3.05 |
ENSMUST00000130273.8
|
Urod
|
uroporphyrinogen decarboxylase |
chr15_+_97259060 | 3.05 |
ENSMUST00000228521.2
ENSMUST00000226495.2 |
Pced1b
|
PC-esterase domain containing 1B |
chr11_-_120930193 | 3.02 |
ENSMUST00000026159.6
|
Cd7
|
CD7 antigen |
chr14_-_60324265 | 3.02 |
ENSMUST00000080368.13
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.0 | 41.9 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
7.6 | 22.9 | GO:0002215 | defense response to nematode(GO:0002215) |
7.3 | 80.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
6.9 | 20.7 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
5.5 | 27.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
5.1 | 15.4 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
4.1 | 12.4 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
4.1 | 12.4 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
3.9 | 19.6 | GO:0097350 | neutrophil clearance(GO:0097350) |
3.6 | 18.0 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
3.6 | 10.7 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
3.5 | 17.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
3.4 | 17.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
3.2 | 9.6 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
2.8 | 11.2 | GO:1900191 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) membrane disruption in other organism(GO:0051673) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
2.7 | 8.1 | GO:0034117 | erythrocyte aggregation(GO:0034117) regulation of erythrocyte aggregation(GO:0034118) |
2.5 | 7.4 | GO:0035702 | monocyte homeostasis(GO:0035702) |
2.4 | 24.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
2.4 | 7.2 | GO:0072249 | metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
1.9 | 15.4 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
1.8 | 5.3 | GO:0071846 | actin filament debranching(GO:0071846) |
1.6 | 13.1 | GO:0031179 | peptide modification(GO:0031179) leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
1.6 | 8.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.6 | 3.2 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
1.6 | 4.7 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
1.6 | 4.7 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
1.5 | 3.1 | GO:0032632 | interleukin-3 production(GO:0032632) |
1.5 | 4.5 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
1.5 | 12.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.5 | 9.0 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
1.5 | 3.0 | GO:0097017 | renal protein absorption(GO:0097017) |
1.5 | 17.6 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
1.4 | 4.3 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
1.4 | 8.7 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
1.4 | 4.3 | GO:0010924 | regulation of inositol-polyphosphate 5-phosphatase activity(GO:0010924) positive regulation of inositol-polyphosphate 5-phosphatase activity(GO:0010925) phospholipase C-inhibiting G-protein coupled receptor signaling pathway(GO:0030845) regulation of cell diameter(GO:0060305) |
1.4 | 18.6 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
1.4 | 1.4 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
1.4 | 5.5 | GO:0033370 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
1.3 | 6.3 | GO:0001805 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
1.2 | 4.8 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
1.2 | 13.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
1.2 | 3.5 | GO:1990051 | negative regulation of phospholipase C activity(GO:1900275) activation of protein kinase C activity(GO:1990051) |
1.1 | 5.6 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
1.1 | 9.9 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.1 | 8.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
1.0 | 3.1 | GO:1904631 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) response to diterpene(GO:1904629) cellular response to diterpene(GO:1904630) response to glucoside(GO:1904631) cellular response to glucoside(GO:1904632) |
1.0 | 3.1 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
1.0 | 4.1 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
1.0 | 16.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
1.0 | 5.1 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
1.0 | 2.0 | GO:0033624 | negative regulation of integrin activation(GO:0033624) |
1.0 | 14.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.0 | 6.7 | GO:0071733 | establishment of protein localization to chromatin(GO:0071169) transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.9 | 5.6 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.9 | 2.7 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.9 | 2.7 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.9 | 2.6 | GO:0051329 | interphase(GO:0051325) mitotic interphase(GO:0051329) |
0.9 | 8.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.9 | 4.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.8 | 21.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.8 | 5.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.8 | 1.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.8 | 17.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.8 | 6.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.7 | 3.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.7 | 2.9 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.7 | 2.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.7 | 10.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.7 | 2.0 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
0.7 | 6.0 | GO:0015879 | carnitine transport(GO:0015879) |
0.7 | 15.9 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.7 | 5.9 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.7 | 5.2 | GO:0042699 | tachykinin receptor signaling pathway(GO:0007217) follicle-stimulating hormone signaling pathway(GO:0042699) |
0.6 | 3.2 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.6 | 2.5 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.6 | 2.5 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.6 | 9.2 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.6 | 1.8 | GO:0070843 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.6 | 2.4 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.6 | 2.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.6 | 3.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.6 | 5.0 | GO:0006108 | malate metabolic process(GO:0006108) |
0.6 | 1.7 | GO:0046072 | dTDP biosynthetic process(GO:0006233) dTDP metabolic process(GO:0046072) |
0.6 | 2.2 | GO:0019046 | release from viral latency(GO:0019046) |
0.5 | 3.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.5 | 8.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.5 | 8.6 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.5 | 2.0 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.5 | 2.9 | GO:0007412 | axon target recognition(GO:0007412) |
0.5 | 2.4 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.5 | 1.9 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.5 | 3.8 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.5 | 1.0 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) |
0.5 | 1.0 | GO:0044413 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.5 | 2.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.5 | 1.9 | GO:1990091 | sodium-dependent self proteolysis(GO:1990091) |
0.5 | 0.9 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.5 | 3.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 3.6 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.4 | 2.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 1.7 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.4 | 3.0 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.4 | 1.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.4 | 0.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.4 | 2.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.4 | 0.8 | GO:0002352 | B cell negative selection(GO:0002352) |
0.4 | 5.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.4 | 2.4 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.4 | 16.9 | GO:0032094 | response to food(GO:0032094) |
0.4 | 3.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.4 | 8.2 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.4 | 3.9 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.4 | 1.9 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.4 | 1.5 | GO:1902896 | terminal web assembly(GO:1902896) |
0.4 | 5.8 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.4 | 1.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.4 | 1.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.4 | 0.8 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.4 | 5.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.4 | 1.1 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.4 | 1.5 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.4 | 1.8 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 2.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 5.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.4 | 1.4 | GO:0060221 | retinal rod cell differentiation(GO:0060221) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) positive regulation of neuromuscular junction development(GO:1904398) |
0.4 | 1.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.4 | 1.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.4 | 2.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 3.1 | GO:0019661 | glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.3 | 2.1 | GO:0050760 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.3 | 0.7 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.3 | 1.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 1.4 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.3 | 2.7 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.3 | 1.0 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.3 | 1.0 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 2.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.3 | 11.5 | GO:0000303 | response to superoxide(GO:0000303) |
0.3 | 2.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.3 | 1.6 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.3 | 3.9 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.3 | 3.5 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 2.8 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.3 | 3.7 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.3 | 2.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.3 | 1.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.3 | 0.9 | GO:0035483 | gastric emptying(GO:0035483) |
0.3 | 1.2 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.3 | 2.5 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 0.8 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.3 | 2.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 1.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 1.6 | GO:0002716 | negative regulation of natural killer cell mediated immunity(GO:0002716) |
0.3 | 2.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 2.5 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 1.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 0.5 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.2 | 44.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 3.4 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.2 | 1.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 2.4 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.2 | 1.9 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 3.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 3.4 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 0.4 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 0.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.2 | 0.9 | GO:0090095 | lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.2 | 0.9 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.2 | 0.8 | GO:0015786 | UDP-glucose transport(GO:0015786) |
0.2 | 1.2 | GO:0015676 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
0.2 | 3.5 | GO:0070986 | left/right axis specification(GO:0070986) |
0.2 | 0.6 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.2 | 1.4 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.8 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.2 | 6.5 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 1.0 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.2 | 0.6 | GO:1903028 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.2 | 0.8 | GO:2000656 | MAPK import into nucleus(GO:0000189) regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.2 | 2.6 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.2 | 1.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.7 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.2 | 1.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 2.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 1.2 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.2 | 1.6 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.2 | 1.0 | GO:0050689 | production of siRNA involved in RNA interference(GO:0030422) targeting of mRNA for destruction involved in RNA interference(GO:0030423) negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 10.9 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 0.5 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.2 | 0.7 | GO:0072021 | ascending thin limb development(GO:0072021) thick ascending limb development(GO:0072023) metanephric ascending thin limb development(GO:0072218) metanephric thick ascending limb development(GO:0072233) |
0.2 | 1.1 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.2 | 0.8 | GO:0070295 | glycerol transport(GO:0015793) renal water absorption(GO:0070295) |
0.2 | 1.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.2 | 4.8 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.2 | 1.4 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.2 | 5.7 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 1.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 2.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 1.6 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 1.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 1.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 5.0 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.8 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 1.7 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 2.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.4 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
0.1 | 4.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.4 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
0.1 | 0.1 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.1 | 2.8 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 5.4 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 1.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.8 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 9.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.7 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.9 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 1.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.6 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.1 | 3.6 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.1 | 1.9 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 3.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 1.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.6 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 2.6 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 4.9 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.5 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 1.0 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.6 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 1.8 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.1 | 2.8 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 2.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 3.0 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 2.7 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.7 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 7.1 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 2.3 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 | 1.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 3.3 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 0.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.2 | GO:1903904 | negative regulation of establishment of T cell polarity(GO:1903904) |
0.1 | 1.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 2.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.9 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 2.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.7 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 1.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.8 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 3.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 1.0 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.1 | 3.9 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 1.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 5.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 2.2 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.1 | 3.4 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 1.8 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 4.2 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 2.5 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.4 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 3.6 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.1 | 0.9 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.7 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 | 0.9 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 2.0 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 1.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 1.2 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 1.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 1.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 2.3 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 1.5 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 1.2 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.0 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.5 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.0 | 0.6 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.0 | 0.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.0 | 0.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 1.0 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 2.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.0 | 0.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:0006649 | phospholipid transfer to membrane(GO:0006649) |
0.0 | 0.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 5.1 | GO:0007596 | blood coagulation(GO:0007596) |
0.0 | 2.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 1.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.0 | 0.6 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 1.7 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 1.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.8 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.4 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.0 | 0.2 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 1.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 2.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.3 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 2.1 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.5 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.2 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 1.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.7 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.0 | 2.1 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.0 | 1.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 3.0 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.5 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.9 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 3.2 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.0 | 0.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.0 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.9 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 1.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 1.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.1 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.0 | 0.9 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.8 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 1.2 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.0 | 2.7 | GO:0007051 | spindle organization(GO:0007051) |
0.0 | 1.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.5 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.2 | GO:0050706 | regulation of interleukin-1 secretion(GO:0050704) regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 0.3 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.1 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.0 | 0.1 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.0 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.1 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.0 | 0.1 | GO:0044805 | late nucleophagy(GO:0044805) |
0.0 | 0.3 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 1.6 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 1.2 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 1.6 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 0.9 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.0 | 0.1 | GO:0045006 | DNA deamination(GO:0045006) DNA cytosine deamination(GO:0070383) positive regulation of mRNA modification(GO:0090366) |
0.0 | 0.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) exosomal secretion(GO:1990182) |
0.0 | 0.3 | GO:0038202 | TORC1 signaling(GO:0038202) |
0.0 | 0.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.3 | GO:0007614 | short-term memory(GO:0007614) |
0.0 | 0.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.4 | 67.2 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
4.1 | 12.4 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
3.7 | 18.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
3.3 | 16.6 | GO:0044194 | cytolytic granule(GO:0044194) |
3.3 | 52.3 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
2.3 | 25.1 | GO:0042629 | mast cell granule(GO:0042629) |
2.0 | 20.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.7 | 6.8 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
1.6 | 9.6 | GO:0042585 | chromosome passenger complex(GO:0032133) germinal vesicle(GO:0042585) |
1.6 | 6.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.5 | 9.0 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
1.3 | 22.8 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.3 | 3.9 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
1.2 | 16.9 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
1.2 | 4.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.2 | 3.5 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
1.1 | 11.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.0 | 14.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.9 | 8.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.9 | 2.8 | GO:1990423 | RZZ complex(GO:1990423) |
0.9 | 9.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.9 | 2.6 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.8 | 2.5 | GO:1903754 | cortical microtubule plus-end(GO:1903754) cytoplasmic microtubule plus-end(GO:1904511) |
0.8 | 3.0 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.7 | 6.7 | GO:0097255 | R2TP complex(GO:0097255) |
0.7 | 3.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.7 | 6.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.7 | 2.9 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.7 | 7.4 | GO:0000235 | astral microtubule(GO:0000235) |
0.7 | 4.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.6 | 3.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.6 | 18.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.6 | 3.6 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.6 | 2.9 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.5 | 1.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.5 | 6.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.5 | 3.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.4 | 2.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.4 | 5.5 | GO:0034709 | methylosome(GO:0034709) |
0.4 | 10.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.4 | 6.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.4 | 7.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 2.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 2.8 | GO:1990246 | uniplex complex(GO:1990246) |
0.4 | 3.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.4 | 14.0 | GO:0097228 | sperm principal piece(GO:0097228) |
0.4 | 1.1 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.4 | 1.9 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 1.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.4 | 3.6 | GO:0061574 | ASAP complex(GO:0061574) |
0.4 | 2.5 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.3 | 20.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 9.6 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.3 | 3.7 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 1.5 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.3 | 0.9 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.3 | 2.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.3 | 2.9 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 3.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 17.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 0.8 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.3 | 1.5 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.3 | 0.8 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.2 | 3.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 3.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 1.6 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 3.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 5.4 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 3.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 3.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 1.2 | GO:0070826 | paraferritin complex(GO:0070826) |
0.2 | 3.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 2.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 23.2 | GO:0019814 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.2 | 1.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 1.0 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 2.1 | GO:1990812 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.2 | 1.5 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 0.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 1.7 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 3.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 7.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 1.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 3.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.4 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 3.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 1.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 0.4 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.1 | 0.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 5.4 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 2.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 4.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 4.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 1.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 3.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 11.4 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 1.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 1.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 33.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 13.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 2.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 1.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 3.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 8.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 4.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.7 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 2.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.9 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.7 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 15.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 1.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 1.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.2 | GO:0043512 | inhibin A complex(GO:0043512) |
0.1 | 0.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 2.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 8.0 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 1.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.2 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.1 | 2.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 3.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.8 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 1.7 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 1.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.7 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 6.8 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 2.0 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 4.9 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 1.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 2.5 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 1.5 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.1 | GO:0098830 | presynaptic endosome(GO:0098830) |
0.0 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 7.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 1.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 1.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 3.7 | GO:0005930 | axoneme(GO:0005930) |
0.0 | 12.3 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 2.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 4.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 3.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 9.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 2.9 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 10.5 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 12.5 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.1 | GO:1904602 | serotonin-activated cation-selective channel complex(GO:1904602) |
0.0 | 4.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.7 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 1.8 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 0.3 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 2.9 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 3.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.3 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.2 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 19.0 | GO:0031720 | haptoglobin binding(GO:0031720) hemoglobin alpha binding(GO:0031721) |
4.2 | 12.5 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
3.0 | 24.4 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
2.5 | 12.6 | GO:0019976 | interleukin-2 binding(GO:0019976) |
2.3 | 13.9 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
2.3 | 13.6 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
2.2 | 17.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
2.2 | 19.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
2.1 | 8.5 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
2.1 | 6.3 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
1.7 | 7.0 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
1.7 | 5.2 | GO:0031753 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
1.7 | 5.0 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
1.6 | 14.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.4 | 4.2 | GO:0097677 | STAT family protein binding(GO:0097677) |
1.3 | 6.5 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
1.3 | 3.8 | GO:0042602 | riboflavin reductase (NADPH) activity(GO:0042602) |
1.2 | 4.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.2 | 5.9 | GO:2001069 | glycogen binding(GO:2001069) |
1.1 | 13.1 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
1.1 | 3.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
1.1 | 3.2 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
1.1 | 10.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.0 | 4.1 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
1.0 | 63.4 | GO:0004601 | peroxidase activity(GO:0004601) |
1.0 | 3.0 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.0 | 2.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.0 | 2.9 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
1.0 | 5.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.9 | 2.8 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.9 | 5.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.8 | 6.7 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.8 | 8.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.8 | 2.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.8 | 4.7 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.8 | 10.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.8 | 3.9 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.8 | 9.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.7 | 3.7 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.7 | 6.0 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.7 | 3.0 | GO:0045159 | myosin II binding(GO:0045159) |
0.7 | 5.2 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.7 | 22.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.7 | 3.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.7 | 4.7 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.7 | 4.0 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.6 | 2.6 | GO:0051435 | BH4 domain binding(GO:0051435) |
0.6 | 2.5 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.6 | 3.1 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.6 | 27.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.6 | 2.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) TIR domain binding(GO:0070976) |
0.6 | 2.4 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.6 | 3.6 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.6 | 4.7 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.6 | 2.9 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.6 | 3.4 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.6 | 1.7 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
0.5 | 17.1 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.5 | 2.1 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.5 | 7.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.5 | 2.0 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.5 | 1.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.5 | 5.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 5.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 2.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.5 | 1.5 | GO:0036004 | GAF domain binding(GO:0036004) |
0.5 | 2.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.5 | 2.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 1.8 | GO:0038100 | nodal binding(GO:0038100) |
0.5 | 4.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.4 | 3.9 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 1.7 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.4 | 10.1 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.4 | 1.6 | GO:0001002 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.4 | 2.7 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.4 | 1.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 7.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.4 | 1.1 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.4 | 8.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.4 | 7.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 2.5 | GO:0031013 | troponin C binding(GO:0030172) troponin I binding(GO:0031013) |
0.4 | 1.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.4 | 1.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.4 | 4.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 1.4 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
0.3 | 19.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.3 | 5.7 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 8.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 0.7 | GO:0019864 | IgG binding(GO:0019864) |
0.3 | 2.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 1.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 4.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 1.5 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 1.2 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.3 | 0.9 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.3 | 1.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 0.8 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.3 | 1.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 1.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.3 | 56.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.3 | 2.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 3.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 3.0 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 2.0 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 1.5 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 4.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 3.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 1.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 7.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.7 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.2 | 0.7 | GO:0015152 | glucose-6-phosphate transmembrane transporter activity(GO:0015152) |
0.2 | 1.6 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.2 | 2.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 2.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 3.7 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.2 | 1.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 9.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 5.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 0.9 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.2 | 0.8 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.2 | 27.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 12.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 1.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 1.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 4.3 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 1.3 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.2 | 1.0 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.2 | 0.6 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
0.2 | 3.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 1.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 3.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 1.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 1.0 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.2 | 1.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 1.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 12.4 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 4.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 2.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 2.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 0.8 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.2 | 25.3 | GO:0002020 | protease binding(GO:0002020) |
0.2 | 0.9 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 1.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 2.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 2.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.7 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 1.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.4 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.1 | 1.6 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.8 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 3.2 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.1 | 0.7 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.1 | 0.9 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 3.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.9 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 4.5 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 1.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 1.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 1.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.1 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.1 | 2.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.9 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 1.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 2.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.9 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
0.1 | 7.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 2.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.8 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.6 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 2.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 1.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 8.5 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.1 | 3.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 2.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 1.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 3.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 2.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 1.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 16.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 4.9 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 4.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 7.0 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.6 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.1 | 6.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.7 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 1.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 1.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 1.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.3 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.1 | 0.4 | GO:0030942 | signal recognition particle binding(GO:0005047) endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 7.8 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.5 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 10.5 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 3.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 3.8 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 1.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 2.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 2.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 6.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 18.6 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 2.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 1.8 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 1.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 19.0 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.0 | 0.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 6.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 1.0 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 1.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 3.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 1.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.7 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.1 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
0.0 | 1.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 1.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 2.2 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.1 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 1.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.0 | 1.5 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 1.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.1 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 1.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.3 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 1.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 1.3 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 3.7 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.5 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.0 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 15.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.7 | 43.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.6 | 13.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 33.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.5 | 27.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.5 | 8.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 18.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 11.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 7.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 17.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.4 | 11.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 2.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 16.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 4.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 11.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 11.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 2.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 4.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 16.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 21.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 6.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 7.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 2.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 25.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 8.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 14.0 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 16.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 2.4 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 9.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 7.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 19.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 4.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 8.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 0.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 3.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 9.0 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 2.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 4.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 2.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 2.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 2.9 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 6.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 14.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 3.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 2.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 2.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 2.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 2.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 4.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 1.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 1.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 2.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 23.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.2 | 4.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.2 | 20.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.0 | 6.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.9 | 19.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.8 | 22.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.8 | 12.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.7 | 12.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.7 | 18.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.7 | 11.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.6 | 21.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 12.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.5 | 12.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 19.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 21.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.4 | 1.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 21.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 19.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 17.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 13.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 5.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 3.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 16.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 4.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 2.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 12.2 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.3 | 9.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.3 | 19.2 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.2 | 1.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 5.9 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.2 | 14.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 2.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 12.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 6.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 5.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 2.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 2.0 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.2 | 11.7 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 2.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 19.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 4.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 2.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 4.9 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.2 | 3.7 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 8.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 4.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 21.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 1.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 3.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 2.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 11.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 13.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.8 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 5.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 3.1 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 3.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 2.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 3.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 5.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 3.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 3.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 3.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 3.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 2.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 7.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 10.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 3.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.8 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 7.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 3.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 4.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.7 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 2.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 4.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 2.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 6.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 2.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 1.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 8.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 1.9 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 1.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 1.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 2.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.9 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 2.8 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.0 | 0.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.2 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |